Search

Your search keyword '"Harden S"' showing total 220 results

Search Constraints

Start Over You searched for: Author "Harden S" Remove constraint Author: "Harden S" Search Limiters Full Text Remove constraint Search Limiters: Full Text
220 results on '"Harden S"'

Search Results

2. EP08.02-23 Is Early Cessation of Chemoradiotherapy Preventing Access to Adjuvant Immunotherapy for Patients with Stage III NSCLC?

5. Weighted composite likelihoods

6. Persisting Gaps in Optimal Care of Stage III Non-small Cell Lung Cancer: An Australian Patterns of Care Analysis

7. Our Ways, Your Ways, Both Ways - a multi-disciplinary collaboration to develop, embed and evaluate a model of social and emotional wellbeing care for Aboriginal and Torres Strait Islander young people who experience detention - Phase 1.

8. EP14.05-016 Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study

9. EP04.01-023 Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry (ANZLCR)

10. Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper

12. The potential for sown tropical perennial grass pastures to improve soil organic carbon in the North-West Slopes and Plains of New South Wales

13. Soil carbon is only higher in the surface soil under minimum tillage in Vertosols and Chromosols of New South Wales North-West Slopes and Plains, Australia

16. Accumulation of soil carbon under zero tillage cropping and perennial vegetation on the Liverpool Plains, eastern Australia

18. Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver

29. Development of intramuscular fat adipocytes in Bos taurus genotypes

34. Implications for UK practice of the use of durvalumab in stage III NSCLC

35. Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer

36. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

37. Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

39. OA13.01 The Impact of [18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial

43. GrassGroTM simulation of pasture, animal performance and greenhouse emissions on low and high sheep productivity grazing systems: 1-year validation and 25-year analysis.

45. Self-referential poetics: embedded song and the performance of poetry in Greek literature

46. MA 11.02 Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update

48. MA 09.11 Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) – a Feasibility Study

49. Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

Catalog

Books, media, physical & digital resources